Kamada (KMDA) Other Operating Expenses (2012 - 2026)
Kamada's (KMDA) quarterly Other Operating Expenses came in at -$21.0 million in Q2 2026, down 7.17% quarter-over-quarter from -$19.6 million in Q1 2026.
Powered by 
Analysis
Kamada (KMDA) Other Operating Expenses (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Other Operating Expenses for 13 consecutive years, with -$21.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Operating Expenses changed N/A year-over-year to -$21.0 million; the trailing twelve-month figure through Jun 2026 stood at -$40.5 million (down 1013825.0% YoY), and the FY2025 full-year result was -$8000.0, down 172.73% from the prior year.
- Other Operating Expenses slipped to -$21.0 million in Q2 2026 per KMDA's latest filing, from -$19.6 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $17000.0 in Q2 2023 and bottomed at -$21.0 million in Q2 2026.
- Historically, Other Operating Expenses has averaged -$5.8 million across 4 years, with a median of -$8000.0 in 2025.
- The sharpest annual moves came in 2024 and 2026: Other Operating Expenses slumped 105.88% in 2024, then plunged 244562.5% in 2026.
- Over 4 years, Other Operating Expenses stood at $17000.0 in 2023, then fell by 29.41% to $12000.0 in 2024, then slumped by 166.67% to -$8000.0 in 2025, then plunged by 262100.0% to -$21.0 million in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$21.0 million, -$19.6 million, and -$8000.0 for Q2 2026, Q1 2026, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.77 Bn | 197.79 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.13 Bn | 177.95 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.89 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.56 Bn | 56.38 Bn | 1.37 Bn |
| 6 | Moderna | 54.38 Bn | 49.24 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.44 Bn | 31.13 Bn | 992.69 Mn |
| 8 | Biogen | 31.17 Bn | 29.89 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.12 Bn | 30.12 Bn | 1.16 Mn |
| 10 | Kamada | 473.28 Mn | 403.14 Mn | 22.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.98 Mn |
| Mar 31, 2026 | -19.57 Mn |
| Mar 31, 2025 | -8,000.00 |
| Sep 30, 2024 | 12,000.00 |
| Jun 30, 2024 | -1,000.00 |
| Jun 30, 2023 | 17,000.00 |
| Mar 31, 2023 | -22,000.00 |
| Jun 30, 2021 | -14.07 Mn |
| Sep 30, 2020 | -1,000.00 |
| Jun 30, 2020 | -6,000.00 |
| Jun 30, 2019 | 4,000.00 |
| Mar 31, 2019 | -6,000.00 |
| Dec 31, 2018 | -15,000.00 |
| Jun 30, 2018 | 4,000.00 |
| Mar 31, 2018 | 66,000.00 |
| Dec 31, 2017 | -3,000.00 |
| Sep 30, 2017 | -49,000.00 |
| Jun 30, 2017 | -45,000.00 |
| Mar 31, 2017 | 18,000.00 |
| Dec 31, 2016 | 5,000.00 |